Showing results (371-380 of 1,109) with videos related to
Sort By:
Pageof 111
Cancer Chemotherapy and Pharmacology|January 1, 1991
Lack of cross-resistance to fostriecin in a human small-cell lung carcinoma cell line showing topoisomerase II-related drug resistanceS de Jong, J G Zijlstra, N H Mulder, et al.International Journal of Surgery Case Reports|March 19, 2013
Right hemothorax: An unusual presentation of a Barrett's ulcer perforationJ H Volders, B Witteman, A H Mulder, et al.Journal of Clinical Pathology|February 1, 1995
Heterotopic ossification induced by hypoxia in a retrosternal gastric tube following transhiatal oesophagectomyH C Buscher, J J van Lanschot, A H Mulder, et al.Clinical and Experimental Immunology|November 1, 1994
Activation of granulocytes by anti-neutrophil cytoplasmic antibodies (ANCA): a Fc gamma RII-dependent processA H Mulder, P Heeringa, E Brouwer, et al.Scandinavian Journal of Gastroenterology|July 27, 2000
Continuous infusion of cholecystokinin leads to down-regulation of the cholecystokinin-A receptor in the rat pancreasB Ohlsson, K Borg, H Mulder, et al.Molecular Neurobiology|September 24, 1999
Pituitary adenylate cyclase-activating polypeptide and islet amyloid polypeptide in primary sensory neurons: functional implications from plasticity in expression on nerve injury and inflammationH Mulder, H Jongsma, Y Zhang, et al.Anticancer Research|April 12, 2003
CDT6-expression can alter tumor sensitivity to chemotherapyDiane Bouïs, Geke A P Hospers, Coby Meijer, et al.Cancer Research|January 15, 1990
Reduced DNA topoisomerase II activity and drug-induced DNA cleavage activity in an adriamycin-resistant human small cell lung carcinoma cell lineS de Jong, J G Zijlstra, E G de Vries, et al.Anticancer Research|September 1, 1995
Review of current clinical experience with prolonged (oral) etoposide in cancer treatmentR S de Jong, N H Mulder, D Dijksterhuis, et al.Diabetologia|December 1, 1993
Chronic overproduction of islet amyloid polypeptide/amylin in transgenic mice: lysosomal localization of human islet amyloid polypeptide and lack of marked hyperglycaemia or hyperinsulinaemiaJ W Höppener, J S Verbeek, E J de Koning, et al.Pageof 111